Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment

Autor: Aamdal, Elin, Skovlund, Eva, Jacobsen, Kari Dolven, Straume, Oddbjørn, Kersten, Christian, Herlofsen, Oluf, Karlsen, Jarle, Hussain, Israr, Amundsen, Anita, Dalhaug, Astrid, Nyakas, Marta Sølvi, Hagene, Kirsten Thorin, Holmsen, Kjersti, Aamdal, Steinar, Kaasa, Stein, Guren, Tormod Kyrre, Kyte, Jon A

Externí odkaz: https://hdl.handle.net/11250/3039568

Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up

Autor: Aamdal, Elin, Jacobsen, Kari Dolven, Straume, Oddbjørn, Kersten, Christian, Herlofsen, Oluf, Karlsen, Jarle, Hussain, Israr, Amundsen, Anita, Dalhaug, Astrid, Nyakas, Marta Sølvi, Schuster, Cornelia, Hagene, Kirsten Thorin, Holmsen, Kjersti, Russnes, Hege Elisabeth Giercksky, Skovlund, Eva, Kaasa, Stein, Aamdal, Steinar, Kyte, Jon A., Guren, Tormod Kyrre

Externí odkaz: https://hdl.handle.net/11250/2987559

Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up.

Autor: Aamdal E; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Jacobsen KD; Department of Oncology, Oslo University Hospital, Oslo, Norway., Straume O; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway., Kersten C; Research Unit, Sørlandet Hospital, Kristiansand, Norway., Herlofsen O; Department of Oncology, Ålesund Hospital, Ålesund, Norway., Karlsen J; The Cancer Clinic, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Hussain I; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway., Amundsen A; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Dalhaug A; Department of Oncology and Palliative Medicine, Nordland Hospital, Norway., Nyakas M; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Schuster C; Department of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway.; Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway., Hagene KT; Department of Oncology, Oslo University Hospital, Oslo, Norway., Holmsen K; Department of Oncology, Oslo University Hospital, Oslo, Norway., Russnes HG; Department of Pathology, Oslo University Hospital, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Skovlund E; Department of Public Health and Nursing, Norwegian University of Science and Technology, NTNU, Trondheim, Norway., Kaasa S; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Aamdal S; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Kyte JA; Department of Oncology, Oslo University Hospital, Oslo, Norway., Guren TK; Department of Oncology, Oslo University Hospital, Oslo, Norway.

Publikováno v: International journal of cancer [Int J Cancer] 2022 Jan 01; Vol. 150 (1), pp. 100-111. Date of Electronic Publication: 2021 Sep 09.